Quick Takeaways
- BML Investment Partners, L.P. filed SCHEDULE 13G/A for Instil Bio, Inc. Common Stock, $0.000001 par value per share (TIL).
- Disclosed ownership: 9.5%.
- Date of event: 31 Dec 2025.
BML Investment Partners, L.P. - 31 Dec 2025 SCHEDULE 13G/A Report for Instil Bio, Inc. Common Stock, $0.000001 par value per share (TIL)
- Filing Manager
- BML Investment Partners, L.P.
- Reporting Manager
- BML Investment Partners, L.P.
- Symbol
- TIL
- Shares outstanding
- 6,795,789 shares
- Disclosed Ownership
- 645,600 shares
- Ownership
- 9.5%
- Form type
- SCHEDULE 13G/A
- Filing time
- 09 Feb 2026, 14:29:48 UTC
- Date of event
- 31 Dec 2025
- Previous filing
- 13 Feb 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"BML Investment Partners, L.P. disclosed 9.5% ownership in Instil Bio, Inc. Common Stock, $0.000001 par value per share (TIL) on 31 Dec 2025."
What Changed
- Previous schedule filing date: 13 Feb 2025.
- Current filing was accepted on 09 Feb 2026, 14:29.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| BML Investment Partners, L.P. | 9.5% | 645,600 | 0 | 645,600 | Braden M Leonard | BML Capital Management, LLC its General Partner By: Braden M Leonard, its Managing Member |